Press "Enter" to skip to content

Posts tagged as “the Kaiser Family Foundation”

CMS Announces First 10 Drugs Subject to Medicare Price Negotiations Under Inflation Reduction Act, Signaling Major Step Towards Lowering Prescription Drug Costs for Medicare Beneficiaries.

CMS has announced the first 10 prescription drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, which is estimated to account for one-fifth of the program's total spending. This shift from the current system, which has been barred from negotiating drug costs, is expected to have a positive impact on the cost of prescription drugs for the 65 million people in the US covered by Medicare.